This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

American Journal Of Obstetrics & Gynecology Welcomes New Editors-in-Chief

Stocks in this article: ENL REN RUK

PHILADELPHIA, September 19, 2013 /PRNewswire/ --

Dr.  Ingrid Nygaard and Dr. Roberto Romero   appointed Editors-in-Chief of AJOG

The American Journal of Obstetrics & Gynecology ( AJOG) today announced with pleasure the appointment of Ingrid Nygaard MD, MS, Professor of Obstetrics and Gynecology at the University of Utah and Roberto Romero, M.D., D.Med.Sci, Chief of the Perinatology Research Branch and Program Head for Perinatal Research and Obstetrics of NICHD/NIH, as the new Editors-in-Chief of AJOG.

Drs. Nygaard and Romero will replace Drs. Thomas Garite and Moon Kim effective January 1, 2014.

Known as the "Gray Journal", AJOG has been a prestigious forum in the field of obstetrics and gynecology for over 100 years, and introduced an innovative print-short/electronic-long format five years ago to meet the needs of its more than 41,000 readers worldwide. With an Impact Factor of 3.877 and an Eigenfactor of 0.05172, AJOG is one of the leading scientific publications in the field of obstetrics and gynecology. AJOG is well-known for its Reports of Major Impact and Clinical Opinions, as well as its original, clinical and translational research, which have changed the lives of women and families.

In their new roles, Drs. Nygaard and Romero will work to strengthen the Journal's scholarly success. Their vision is to grow AJOG into a high quality and high impact journal supported by a robust multimedia online platform with a user-friendly interface.

"Building on the prestige and excellence of AJOG, we are looking forward to introducing innovative methods to convey information about clinical practice and science," said Dr. Romero. "The biomedical journal of the 21 st century needs to be timely, efficient, and practical, and use formats that meet the evolving needs of obstetricians, gynecologists, and our patients worldwide."

"By maximizing AJOG's focus on cutting-edge, evidence-based research and reader-friendly data synthesis and presentation, we will work to position the Journal as the leader in disseminating high-quality information in the field of women's health," added Dr. Nygaard.

"Drs. Nygaard and Romero make a strong team and I look forward to working with them to publish the finest work in the field in ways that engage and educate our busy readers," said Andrea Boccelli, Publisher at Elsevier. Elsevier is confident that these two leaders in women's health will succeed in elevating AJOG's already strong standing. Their commitment, skills, and expertise will support the Journal's goal of improving the lives of women and their babies by disseminating the best science to researchers and clinicians."

About  American Journal of Obstetrics & Gynecology

AJOG, has been a prestigious forum in obstetrics and gynecology for over 100 years, and is currently read by more than 41,000 obstetricians and gynecologists across the globe. With an impact factor of 3.877 and an Eigenfactor of 0.05172, AJOG is a leading scientific publication in the field of obstetrics and gynecology. For more information, go to: http://www.ajog.org

About Elsevier

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
Try it NOW
Try it NOW
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

Jim Cramer's protégé, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,416.85 +225.48 1.31%
S&P 500 2,021.25 +19.09 0.95%
NASDAQ 4,683.4070 +45.4130 0.98%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs